Plasma myeloperoxidase level and peripheral arterial disease.

doi:10.1111/j.1365-2362.2011.02601.x

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Plasma myeloperoxidase level and peripheral arterial disease.

European journal of clinical investigation - 1 May 2012

Haslacher Helmuth, Perkmann Thomas, Gruenewald Julia, Exner Markus, Endler Georg, Scheichenberger Vanessa, Wagner Oswald, Schillinger Martin

Abstract excerpt

BACKGROUND: Myeloperoxidase (MPO) is involved in a multitude of inflammatory processes involving oxidative modification of soluble components and cellular surfaces. Thus, MPO plays a key role in promoting atherosclerosis via oxidative stress by modification of both high- and low-density lipoprotein and production of other bioactive molecules. A polymorphism (MPO 463G>A, rs2333227) results in different expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Biomarkers

Share to Atherosclerosis

Share to Cardiovascular Diseases

Share to Peripheral Arterial Disease

Share to Peroxidase

Share to Predictive Value of Tests

Share to Risk Factors

Source

Open in PubMed

Identifiers

PMID: 21950958
DOI: 10.1111/j.1365-2362.2011.02601.x

Genes

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma myeloperoxidase level and peripheral arterial disease.PMID 21950958Read ↗

Effects of myeloperoxidase -463 G/A gene polymorphism and plasma levels on coronary artery disease.Semantic proximity Read ↗

Genetic polymorphisms of myeloperoxidase and their effect on hypertension.Semantic proximity Read ↗

Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: genetic determinants for atherosclerosis?Semantic proximity Read ↗

The myeloperoxidase -463G/A polymorphism and coronary artery disease risk: A meta-analysis of 1938 cases and 1990 controls.Semantic proximity Read ↗

Meta-analysis of myeloperoxidase gene polymorphism and coronary artery disease susceptibility.Semantic proximity Read ↗

Association between myeloperoxidase polymorphisms and its plasma levels with severity of coronary artery disease.Semantic proximity Read ↗

Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms.Semantic proximity Read ↗

Myeloperoxidase polymorphism and coronary artery disease risk: A meta-analysis.Semantic proximity Read ↗

PRISMA-combined Myeloperoxidase -463G/A gene polymorphism and coronary artery disease: A meta-analysis of 4744 subjects.Semantic proximity Read ↗

Myeloperoxidase G-463A polymorphism and susceptibility to coronary artery disease: a meta-analysis.Semantic proximity Read ↗

No relationship between neutrophil granulocyte activation and the myeloperoxidase gene - 129 G>A and - 463 G>A promoter polymorphisms: implications for investigations of cardiovascular disease.Semantic proximity Read ↗

SNP rs2243828 in MPO associated with myeloperoxidase level and atrial fibrillation risk in Chinese Han population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.